RECURSION PHARMACEUTICALS, INC. RXRX 深 滬
等待開盤 10-17 09:30:00 美东时间
6.36
-0.430
-6.33%
華盛通- 最 高7.04
- 今 開6.79
- 成交量 2.29亿股
- 最 低 6.25
- 昨 收 6.79
- 總市值 27.60亿
- 52周最高 12.36
- 市盈率 靜 --
- 換手率 52.74%
- 52周最低 3.79
- 委 比 -24.16%
- 總股本 4.34亿
- 歷史最高 42.81
- 量 比 2.53
- 振 幅 11.63%
- 歷史最低 3.79
- 每 手 1
- 風險率 1.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 300 points on ...
10-15 22:47
美股夜盘 | MP Materials Corporation Ordinary Shares - Class A涨5.45%，MicroAlgo涨4.59%
MP Materials Corporation Ordinary Shares - Class A涨5.45%；MicroAlgo涨4.59%；名创优品涨3.27%
10-09 12:02
What's Going On With Recursion Pharmaceuticals Stock On Wednesday?
Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 and extended cash runway.
10-09 02:51
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 100 points on ...
10-08 22:39
Jim Cramer Says This Financial Stock Is A 'Total Spec,' Likes Dutch Bros,
On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Dutch Bros (NYSE: BROS). He recommended buying some now and then buying some of the stock in the $40s.
09-26 20:36
“生物科技大牛股猎手”Needham押宝这家“AI+新药研发”领军者 押注股价将狂飙68%
Needham 维持对 Recursion Pharmaceuticals 的“买入”评级，目标价维持在8美元。
09-16 12:10
美股大行评级 | 潜在涨幅208.48%！HC Wainwright & Co.上调Microbot Medical目标价至12美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Microbot Medical"买入"评级，目标价从9美元升至12美元；Maxim Group：维持Neuphoria Therapeutics"买入"评级，目标价从18美元升至35美元
09-12 12:53
What Analysts Are Saying About Recursion Pharmaceuticals Stock
4 analysts have expressed a variety of opinions on Recursion Pharmaceuticals (N...
09-11 21:00
Needham Reiterates Buy on Recursion Pharmaceuticals, Maintains $8 Price Target
Needham analyst Gil Blum reiterates Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy and maintains $8 price target.
09-11 19:15
